Search

Author/Creator Fecher, Leslie

1. 241 Clinical outcomes of metastatic melanoma patients with liver metastases treated with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab. (9th November 2020)

Authors:
Ma, Vincent; Griffith, Kent; Waninger, Jessica; Daignault-Newton, Stephanie; Fecher, Leslie; Alva, Ajjai; Lao, Christopher
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A143
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 241 Clinical outcomes of metastatic melanoma patients with liver metastases treated with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab. (9th November 2020)

Authors:
Ma, Vincent; Griffith, Kent; Waninger, Jessica; Daignault-Newton, Stephanie; Fecher, Leslie; Alva, Ajjai; Lao, Christopher
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0. Issue 1 (30th May 2018)

Authors:
Sullivan, Ryan J.; Atkins, Michael B.; Kirkwood, John M.; Agarwala, Sanjiv S.; Clark, Joseph I.; Ernstoff, Marc S.; Fecher, Leslie; Gajewski, Thomas F.; Gastman, Brian; Lawson, David H.; Lutzky, Jose; McDermott, David F.; Margolin, Kim A.; Mehnert, Janice M.; Pavlick, Anna C.; Richards, Jon M.; R...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 6:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy. Issue 7 (15th July 2019)

Authors:
Tsung, Irene; Dolan, Russell; Lao, Christopher D.; Fecher, Leslie; Riggenbach, Kane; Yeboah‐Korang, Amoah; Fontana, Robert J.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 50:Issue 7(2019)
Page Start:
800
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline. Issue 35 (10th December 2021)

Authors:
Santomasso, Bianca D.; Nastoupil, Loretta J.; Adkins, Sherry; Lacchetti, Christina; Schneider, Bryan J.; Anadkat, Milan; Atkins, Michael B.; Brassil, Kelly J.; Caterino, Jeffrey M.; Chau, Ian; Davies, Marianne J.; Ernstoff, Marc S.; Fecher, Leslie; Funchain, Pauline; Jaiyesimi, Ishmael; Mammen, J...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 35(2021)
Page Start:
3978
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. Issue 36 (20th December 2021)

Authors:
Schneider, Bryan J.; Naidoo, Jarushka; Santomasso, Bianca D.; Lacchetti, Christina; Adkins, Sherry; Anadkat, Milan; Atkins, Michael B.; Brassil, Kelly J.; Caterino, Jeffrey M.; Chau, Ian; Davies, Marianne J.; Ernstoff, Marc S.; Fecher, Leslie; Ghosh, Monalisa; Jaiyesimi, Ishmael; Mammen, Jennifer...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 36(2021)
Page Start:
4073
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗